{"id":"NCT04362137","sponsor":"Novartis Pharmaceuticals","briefTitle":"Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm","officialTitle":"Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-05-02","primaryCompletion":"2020-10-17","completion":"2020-10-17","firstPosted":"2020-04-24","resultsPosted":"2021-06-02","lastUpdate":"2021-10-11"},"enrollment":432,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Cytokine Storm (Covid-19)"],"interventions":[{"type":"DRUG","name":"Ruxolitinib","otherNames":["INC424"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Ruxolitinib 5 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This was a randomized, double-blind, placebo-controlled, 29-day, multicenter study to assess the efficacy and safety of ruxolitinib + standard-of-care (SoC) therapy, compared with placebo + SoC therapy, in patients aged ≥12 years with COVID-19 disease.","primaryOutcome":{"measure":"Proportion of Patients Who Die, Develop Respiratory Failure [Require Mechanical Ventilation] or Require Intensive Care Unit (ICU) Care","timeFrame":"Day 1 - Day 29","effectByArm":[{"arm":"Ruxolitinib 5 mg","deltaMin":34,"sd":null},{"arm":"Placebo","deltaMin":17,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.769"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":null},"locations":{"siteCount":61,"countries":["United States","Argentina","Brazil","Colombia","France","Germany","Mexico","Peru","Russia","Spain","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":["35368384"],"seeAlso":["https://www.novctrd.com/ctrdweb/patientsummary/patientsummaries?patientSummaryId=942"]},"adverseEventsSummary":{"seriousAny":{"events":31,"n":281},"commonTop":["Headache","Diarrhoea","Alanine aminotransferase increased","Nausea","Constipation"]}}